Visiplex buys Nuclear Data camera
Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is
Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is the first step in a Visiplex plan toacquire Nuclear Data's entire line of film recorders, accordingto the Elmsford, NY, company.
Visiplex intends to dominate the field of multiformat camerasas long as the technology is available and plans to increase itsmarket share through acquisition, according to Seamus Carroll,vice president of sales and marketing. Visiplex moved into PACSwith the acquisition of Genesys earlier this year (SCAN 8/10/94).
At the RSNA meeting, Visiplex displayed MRI Read Station, a three-monitorconfiguration of Imlogix displays developed for MRI studies. Visiplexalso displayed a new Windows-based version of the FilmFax productformerly marketed by Genesys.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
